The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Beyond TILs: Predictors of pathologic complete response (pCR) in triple-negative breast cancer (TNBC) patients with moderate tumor-infiltrating lymphocytes (TIL) receiving neoadjuvant therapy.
 
Nour Abuhadra
No Relationships to Disclose
 
Kenneth R. Hess
No Relationships to Disclose
 
Jennifer Keating Litton
Consulting or Advisory Role - AstraZeneca; Medivation/Pfizer; Pfizer
Speakers' Bureau - Med Learning Group; Medscape; Physicans' Education Resource; UpToDate
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Jounce Therapeutics (Inst); Medivation/Pfizer (Inst); Novartis (Inst); pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Med Learning Group; Medscape; Physicans' Education Resource
 
Gaiane M Rauch
No Relationships to Disclose
 
Alastair Mark Thompson
Honoraria - Novartis (I); Pfizer
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Novartis (I); Pfizer
 
Bora Lim
Consulting or Advisory Role - AstraZeneca; Novartis
Research Funding - Calithera Biosciences; Genentech; Merck; Puma Biotechnology; Takeda
 
Beatriz E Adrada
No Relationships to Disclose
 
Elizabeth A. Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Merck; Peregrine Pharmaceuticals; Sellas Life Sciences; TapImmune Inc.
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Galena Biopharma (Inst); Genentech/Roche (Inst)
 
Senthil Damodaran
Consulting or Advisory Role - Pfizer; Taiho Pharmaceutical; Tempus
Research Funding - EMD Serono; Guardant Health
 
Rosalind P Candelaria
No Relationships to Disclose
 
Banu Arun
Research Funding - Abbvie; PharmaMar
Travel, Accommodations, Expenses - AstraZeneca
 
Wei Tse Yang
Consulting or Advisory Role - Bayer; GE Healthcare; Seno Medical; Siemens Healthineers; Wolters Kluwer
Patents, Royalties, Other Intellectual Property - Elsevier Royalties
Travel, Accommodations, Expenses - GE Healthcare; Siemens Healthineers
 
Naoto T. Ueno
Honoraria - Amgen; Chugai Pharma; Kyowa Hakko Kirin; Roche
Consulting or Advisory Role - Samsung Bioepis
Research Funding - Amgen; Bayer; Bio-Path Holdings; Celgene; Daiichi Sankyo; GlaxoSmithKline; Kyowa Hakko Kirin; Medivation; Merck; Novartis; Puma Biotechnology; Sysmex
Travel, Accommodations, Expenses - Kyowa Hakko Kirin
 
Lumarie Santiago
No Relationships to Disclose
 
Rashmi Krishna Murthy
Consulting or Advisory Role - Genentech; Genentech/Roche; Puma Biotechnology
Research Funding - Cascadian Therapeutics (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Pfizer (Inst)
 
Nuhad K. Ibrahim
Honoraria - Celgene; Novartis; Roche
Consulting or Advisory Role - Immunomedics
Speakers' Bureau - Celgene; Novartis; Roche
Research Funding - Nektar
Travel, Accommodations, Expenses - Novartis; Roche
 
Aysegul A. Sahin
No Relationships to Disclose
 
William Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; ISIS Pharmaceuticals; Nuvera Biosciences
Consulting or Advisory Role - Almac Diagnostics; Merck
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
Travel, Accommodations, Expenses - Luminex; Merck
 
Stacy L. Moulder
Honoraria - Novartis; Pfizer (I)
Research Funding - Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Genentech (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer (I)
 
Lei Huo
No Relationships to Disclose